Vera Therapeutics, Inc. (VERA)

NGM – Real Time Price. Currency in USD

30.17

-0.12 (-0.40%)

Market open: Aug 12, 2026, 2:07 PM EDT

30.78

+0.49 (1.62%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-468K

-2M

846K

Gross Profit

-468K

-2M

846K

Operating expenses (excl. COGS)

-315M

-165M

-104M

-92M

Operating Income

-315M

-167M

-102M

-91M

Non-operating income, total

16M

15M

Pretax income

-300M

-152M

-96M

-89M

Equity in earnings

Taxes

-1K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-300M

-152M

-96M

-89M

Discontinued operations

Net income

-300M

-152M

-96M

-89M

Dilution adjustment

Preferred dividends

Vera Therapeutics, Inc. (VERA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vera Therapeutics, Inc. (VERA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Vera Therapeutics, Inc. (VERA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vera Therapeutics, Inc. (VERA)

Income Statement (Annual)

Income Statement (Annual)